Cargando…
The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
BACKGROUND: Despite our growing knowledge about the pathomechanisms of cancer cachexia, a whole clinical picture of the cachectic patient is still missing. Our objective was to evaluate the clinical characteristics in cancer patients with and without cachexia to get the whole picture of a cachectic...
Autores principales: | Schwarz, S., Prokopchuk, O., Esefeld, K., Gröschel, S., Bachmann, J., Lorenzen, S., Friess, H., Halle, M., Martignoni, M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307774/ https://www.ncbi.nlm.nih.gov/pubmed/28193264 http://dx.doi.org/10.1186/s12885-017-3116-9 |
Ejemplares similares
-
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
por: Mueller, Tara C., et al.
Publicado: (2016) -
Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003) -
A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
por: Prokopchuk, Olga, et al.
Publicado: (2021) -
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
por: Prokopchuk, Olga, et al.
Publicado: (2018) -
Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status
por: Chovsepian, Alexandra, et al.
Publicado: (2023)